157 related articles for article (PubMed ID: 34868308)
1. Chemerin/CMKLR1 Axis Promotes the Progression of Proliferative Diabetic Retinopathy.
Wang L; Zhang Y; Guo Y; Ding W; Chang A; Wei J; Li X; Qian H; Zhu C
Int J Endocrinol; 2021; 2021():4468625. PubMed ID: 34868308
[TBL] [Abstract][Full Text] [Related]
2. Increased Serum Chemerin Levels in Diabetic Retinopathy of Type 2 Diabetic Patients.
Du J; Li R; Xu L; Ma R; Liu J; Cheng J; Zhang Z; Sun H
Curr Eye Res; 2016; 41(1):114-20. PubMed ID: 25848840
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of cytokines in the aqueous humor correlate with the severity of diabetic retinopathy.
Song S; Yu X; Zhang P; Dai H
J Diabetes Complications; 2020 Sep; 34(9):107641. PubMed ID: 32605862
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of diabetic retinopathy, proliferative diabetic retinopathy and non-proliferative diabetic retinopathy in Asian T2DM patients: a systematic review and Meta-analysis.
Yang QH; Zhang Y; Zhang XM; Li XR
Int J Ophthalmol; 2019; 12(2):302-311. PubMed ID: 30809489
[TBL] [Abstract][Full Text] [Related]
5. Increased Vitreous Chemerin Levels Are Associated with Proliferative Diabetic Retinopathy.
Li J; Hu WC; Song H; Lin JN; Tang X
Ophthalmologica; 2016; 236(2):61-6. PubMed ID: 27548269
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-15b Targets VEGF and Inhibits Angiogenesis in Proliferative Diabetic Retinopathy.
Yang Y; Liu Y; Li Y; Chen Z; Xiong Y; Zhou T; Tao W; Xu F; Yang H; Ylä-Herttuala S; Chaurasia SS; Adam WC; Yang K
J Clin Endocrinol Metab; 2020 Nov; 105(11):3404-15. PubMed ID: 32797181
[TBL] [Abstract][Full Text] [Related]
7. Association of the serum chemerin level with the development of diabetic retinopathy in patients with type 1 diabetes mellitus.
Elmahdy AG; Ibrahim MM; Salama OH; Ziada HEA; Ali MM; Elmohaseb GF; Youssef EM; Bayoumy ES; Bayomy MA; Mohamed SA
Med Hypothesis Discov Innov Ophthalmol; 2022; 11(4):171-178. PubMed ID: 37641604
[TBL] [Abstract][Full Text] [Related]
8. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N
Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of CMKLR1 in endometriosis and its relationship with inflammatory responses.
Zhang Z; Ding Y; Li J; Su S
Histol Histopathol; 2023 Mar; 38(3):329-337. PubMed ID: 36156768
[TBL] [Abstract][Full Text] [Related]
10. Effects of fenofibrate on inflammatory cytokines in diabetic retinopathy patients.
Ju HB; Zhang FX; Wang S; Song J; Cui T; Li LF; Zhang HY
Medicine (Baltimore); 2017 Aug; 96(31):e7671. PubMed ID: 28767589
[TBL] [Abstract][Full Text] [Related]
11. American Society of Retina Specialists Clinical Practice Guidelines on the Management of Nonproliferative and Proliferative Diabetic Retinopathy without Diabetic Macular Edema.
Yonekawa Y; Modi YS; Kim LA; Skondra D; Kim JE; Wykoff CC
J Vitreoretin Dis; 2020 Mar; 4(2):125-135. PubMed ID: 34308094
[TBL] [Abstract][Full Text] [Related]
12. Interaction Between the Distribution of Diabetic Retinopathy Lesions and the Association of Optical Coherence Tomography Angiography Scans With Diabetic Retinopathy Severity.
Ashraf M; Sampani K; Rageh A; Silva PS; Aiello LP; Sun JK
JAMA Ophthalmol; 2020 Dec; 138(12):1291-1297. PubMed ID: 33119083
[TBL] [Abstract][Full Text] [Related]
13. Serum Vascular Endothelial Growth Factor Levels Correlate with Severity of Retinopathy in Diabetic Patients: A Systematic Review and Meta-Analysis.
Zhou Z; Ju H; Sun M; Chen H
Dis Markers; 2019; 2019():9401628. PubMed ID: 31019585
[TBL] [Abstract][Full Text] [Related]
14. Role of Angiopoietins and Tie-2 in Diabetic Retinopathy.
Khalaf N; Helmy H; Labib H; Fahmy I; El Hamid MA; Moemen L
Electron Physician; 2017 Aug; 9(8):5031-5035. PubMed ID: 28979738
[TBL] [Abstract][Full Text] [Related]
15. Effects of laser photocoagulation on serum angiopoietin-1, angiopoietin-2, angiopoietin-1/angiopoietin-2 ratio, and soluble angiopoietin receptor Tie-2 levels in type 2 diabetic patients with proliferative diabetic retinopathy.
You QY; Zhuge FY; Zhu QQ; Si XW
Int J Ophthalmol; 2014; 7(4):648-53. PubMed ID: 25161936
[TBL] [Abstract][Full Text] [Related]
16. Chemerin/CMKLR1 Axis Promotes Inflammation and Pyroptosis by Activating NLRP3 Inflammasome in Diabetic Cardiomyopathy Rat.
Xie Y; Huang Y; Ling X; Qin H; Wang M; Luo B
Front Physiol; 2020; 11():381. PubMed ID: 32390873
[TBL] [Abstract][Full Text] [Related]
17. Serum fetuin-A levels are independently correlated with vascular endothelial growth factor and C-reactive protein concentrations in type 2 diabetic patients with diabetic retinopathy.
Zhou ZW; Ju HX; Sun MZ; Fu QP; Chen HM; Ji HB; Ji F; Jiang DM
Clin Chim Acta; 2016 Apr; 455():113-7. PubMed ID: 26851648
[TBL] [Abstract][Full Text] [Related]
18. Low blood and vitreal BDNF, LXA4 and altered Th1/Th2 cytokine balance are potential risk factors for diabetic retinopathy.
Kaviarasan K; Jithu M; Arif Mulla M; Sharma T; Sivasankar S; Das UN; Angayarkanni N
Metabolism; 2015 Sep; 64(9):958-66. PubMed ID: 26004392
[TBL] [Abstract][Full Text] [Related]
19. Aqueous Levels of Angiopoietin-like 4 and Semaphorin 3E Correlate with Nonperfusion Area and Macular Volume in Diabetic Retinopathy.
Kwon SH; Shin JP; Kim IT; Park DH
Ophthalmology; 2015 May; 122(5):968-75. PubMed ID: 25687026
[TBL] [Abstract][Full Text] [Related]
20. Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab.
Bressler SB; Liu D; Glassman AR; Blodi BA; Castellarin AA; Jampol LM; Kaufman PL; Melia M; Singh H; Wells JA;
JAMA Ophthalmol; 2017 Jun; 135(6):558-568. PubMed ID: 28448655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
